IV Corticosteroid ( DrugBank: - )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
97	Ulcerative colitis	2

97. Ulcerative colitis

---

Clinical trials : 2,527 /  Drugs : 1,465 - (DrugBank : 259) / Drug target genes : 144 - Drug target pathways : 202

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01941589 (ClinicalTrials.gov)	September 2013	30/8/2013	Corticosteroids+5-aminosalicylic Acid Compared to Corticosteroids in the Treatment of Moderate-severe Ulcerative Colitis	Combination Corticosteroids + 5-aminosalicylic Acids Compared to Corticosteroids Alone in the Treatment of Moderate-severe Active Ulcerative Colitis.	Ulcerative Colitis	Drug: oral 5-ASA+/-topical 5-ASA+IV corticosteroids / PO Methylprednisolone;Drug: corticosteroids only	Sheba Medical Center	NULL	Recruiting	18 Years	N/A	All	160	Phase 4	China;France;Greece;Israel;Italy;Korea, Republic of;Serbia
2	NCT01536535 (ClinicalTrials.gov)	July 10, 2012	16/2/2012	Predicting Response to Standardized Pediatric Colitis Therapy	Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.	Ulcerative Colitis	Drug: Mesalazine;Drug: IV Corticosteroid;Drug: Oral Corticosteroids;Other: Additional Therapies;Procedure: Colectomy	Connecticut Children's Medical Center	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	Completed	4 Years	17 Years	All	431	Phase 4	United States;Canada